Literature DB >> 33603362

Lipoparticles for Synergistic Chemo-Photodynamic Therapy to Ovarian Carcinoma Cells: In vitro and in vivo Assessments.

Sajid Ali1, Muhammad Umair Amin1,2, Imran Tariq1,3, Muhammad Farhan Sohail4,5, Muhammad Yasir Ali1,6, Eduard Preis1, Ghazala Ambreen1, Shashank Reddy Pinnapireddy1, Jarmila Jedelská1, Jens Schäfer1, Udo Bakowsky1.   

Abstract

PURPOSE: Lipoparticles are the core-shell type lipid-polymer hybrid systems comprising polymeric nanoparticle core enveloped by single or multiple pegylated lipid layers (shell), thereby melding the biomimetic properties of long-circulating vesicles as well as the mechanical advantages of the nanoparticles. The present study was aimed at the development of such an integrated system, combining the photodynamic and chemotherapeutic approaches for the treatment of multidrug-resistant cancers.
METHODS: For this rationale, two different sized Pirarubicin (THP) loaded poly lactic-co-glycolic acid (PLGA) nanoparticles were prepared by emulsion solvent evaporation technique, whereas liposomes containing Temoporfin (mTHPC) were prepared by lipid film hydration method. Physicochemical and morphological characterizations were done using dynamic light scattering, laser doppler anemometry, atomic force microscopy, and transmission electron microscopy. The quantitative assessment of cell damage was determined using MTT and reactive oxygen species (ROS) assay. The biocompatibility of the nanoformulations was evaluated with serum stability testing, haemocompatibility as well as acute in vivo toxicity using female albino (BALB/c) mice. RESULTS AND
CONCLUSION: The mean hydrodynamic diameter of the formulations was found between 108.80 ± 2.10 to 405.70 ± 10.00 nm with the zeta (ζ) potential ranging from -12.70 ± 1.20 to 5.90 ± 1.10 mV. Based on the physicochemical evaluations, the selected THP nanoparticles were coated with mTHPC liposomes to produce lipid-coated nanoparticles (LCNPs). A significant (p< 0.001) cytotoxicity synergism was evident in LCNPs when irradiated at 652 nm, using an LED device. No incidence of genotoxicity was observed as seen with the comet assay. The LCNPs decreased the generalized in vivo toxicity as compared to the free drugs and was evident from the serum biochemical profile, visceral body index, liver function tests as well as renal function tests. The histopathological examinations of the vital organs revealed no significant evidence of toxicity suggesting the safety and efficacy of our lipid-polymer hybrid system.
© 2021 Ali et al.

Entities:  

Keywords:  FACS; PLGA nanoparticles; TEM; atomic force microscopy; in vitro cytotoxicity; in vivo; lipid-polymer hybrid nanoparticles; photodynamic therapy

Mesh:

Substances:

Year:  2021        PMID: 33603362      PMCID: PMC7884954          DOI: 10.2147/IJN.S285950

Source DB:  PubMed          Journal:  Int J Nanomedicine        ISSN: 1176-9114


  59 in total

1.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers.

Authors:  M N V Ravi Kumar; U Bakowsky; C M Lehr
Journal:  Biomaterials       Date:  2004-05       Impact factor: 12.479

2.  Redistribution of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from conventional and PEGylated liposomes to biological substrates.

Authors:  Vadzim Reshetov; Dzmitry Kachatkou; Tatiana Shmigol; Vladimir Zorin; Marie-Ange D'Hallewin; Francois Guillemin; Lina Bezdetnaya
Journal:  Photochem Photobiol Sci       Date:  2011-02-10       Impact factor: 3.982

Review 3.  Programmable nanomedicine: synergistic and sequential drug delivery systems.

Authors:  Dennis B Pacardo; Frances S Ligler; Zhen Gu
Journal:  Nanoscale       Date:  2015-02-28       Impact factor: 7.790

4.  Cell to rodent: toxicological profiling of folate grafted thiomer enveloped nanoliposomes.

Authors:  Muhammad Farhan Sohail; Hafiz Shoaib Sarwar; Ibrahim Javed; Akhtar Nadhman; Syed Zajif Hussain; Hamid Saeed; Abida Raza; Nadeem Irfan Bukhari; Irshad Hussain; Gul Shahnaz
Journal:  Toxicol Res (Camb)       Date:  2017-07-24       Impact factor: 3.524

5.  Shrinkage of pegylated and non-pegylated liposomes in serum.

Authors:  Joy Wolfram; Krishna Suri; Yong Yang; Jianliang Shen; Christian Celia; Massimo Fresta; Yuliang Zhao; Haifa Shen; Mauro Ferrari
Journal:  Colloids Surf B Biointerfaces       Date:  2013-10-24       Impact factor: 5.268

6.  Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs.

Authors:  Brian C Evans; Christopher E Nelson; Shann S Yu; Kelsey R Beavers; Arnold J Kim; Hongmei Li; Heather M Nelson; Todd D Giorgio; Craig L Duvall
Journal:  J Vis Exp       Date:  2013-03-09       Impact factor: 1.355

7.  Toxicological Study of Ocimum sanctum Linn Leaves: Hematological, Biochemical, and Histopathological Studies.

Authors:  M K Gautam; R K Goel
Journal:  J Toxicol       Date:  2014-01-29

8.  Biochemical Evaluation of Silver Nanoparticles in Wistar Rats.

Authors:  Oluyomi Stephen Adeyemi; Ifeoluwa Adewumi
Journal:  Int Sch Res Notices       Date:  2014-10-30

9.  Lecithin-gold hybrid nanocarriers as efficient and pH selective vehicles for oral delivery of diacerein-In-vitro and in-vivo study.

Authors:  Ibrahim Javed; Syed Zajif Hussain; Atif Shahzad; Jahanzeb Muhammad Khan; Habib Ur-Rehman; Mubashar Rehman; Faisal Usman; Muhammad Tahir Razi; Muhammad Raza Shah; Irshad Hussain
Journal:  Colloids Surf B Biointerfaces       Date:  2016-01-15       Impact factor: 5.268

10.  Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats.

Authors:  Rob J Vandebriel; Elisa Cm Tonk; Liset J de la Fonteyne-Blankestijn; Eric R Gremmer; Henny W Verharen; Leo T van der Ven; Henk van Loveren; Wim H de Jong
Journal:  Part Fibre Toxicol       Date:  2014-05-07       Impact factor: 9.400

View more
  1 in total

1.  Co-delivery of carbonic anhydrase IX inhibitor and doxorubicin as a promising approach to address hypoxia-induced chemoresistance.

Authors:  Muhammad Umair Amin; Sajid Ali; Muhammad Yasir Ali; Dominik C Fuhrmann; Imran Tariq; Benjamin S Seitz; Eduard Preis; Jana Brüßler; Bernhard Brüne; Udo Bakowsky
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.